NCT01922921 2023-04-18
Vaccine Therapy With or Without Polysaccharide-K in Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy
University of Washington
Phase 1/2 Completed
Clinical Trials
8 trialsNCT00216034 2016-06-07
Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK
Hokuriku-Kinki Immunochemotherapy Study Group
Phase 3 Completed
NCT01685489 2015-10-27
A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer
Bastyr University
Phase 1 Withdrawn
NCT00385970 2012-10-26
A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal Cancer
Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group
Phase 3 Unknown
NCT00687843 2012-03-22
TMOG-GC01
Tokyo Metropolitan Oncology Group
Phase 3 Unknown
NCT00209742 2010-05-26
Randomized Phase III Adjuvant Study for Stage III Colorectal Cancer
Hokkaido Gastrointestinal Cancer Study Group
Phase 3 Unknown
NCT00503321 2009-01-23
eNCIT-Japan
Eastern Network of Cancer Immunological Therapy, Japan
Phase 2/3 Terminated
NCT00546130 2008-09-03
RNCLC
University of Toyama
Phase 2 Unknown